Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 199Rectal Neoplasms 106Colonic Neoplasms 78Stomach Neoplasms 64Pancreatic Neoplasms 56Neoplasm Metastasis 50Esophageal Neoplasms 34Neoplasms 25Lymphoma 24Leukemia 24Adenocarcinoma Of Esophagus 22Burkitt Lymphoma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Carcinoma, Hepatocellular 16Cholangiocarcinoma 15Adenocarcinoma 15Biliary Tract Neoplasms 12Gallbladder Neoplasms 9Bile Duct Neoplasms 8Lymphoma, Mantle-Cell 7Colorectal Cancer Metastatic 7Osteosarcoma 6Esophageal Squamous Cell Carcinoma 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Liver Neoplasms 5Dendritic Cell Sarcoma, Interdigitating 5Breast Neoplasms 5Sarcoma 4Peritoneal Neoplasms 4

Interventions

dehydroftorafur 1Taxes 1Ramucirumab 1Paclitaxel 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metastatic Small Intestinal Adenocarcinoma × Leucovorin × Clear all
NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

SWOG Cancer Research Network

Phase 2 Recruiting
94 enrolled

Metastatic Small Intestinal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡